Effect of Sex Steroid Hormones on Tongue Cancer Cells


Journal

Anticancer research
ISSN: 1791-7530
Titre abrégé: Anticancer Res
Pays: Greece
ID NLM: 8102988

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 09 09 2020
revised: 22 09 2020
accepted: 24 09 2020
entrez: 28 10 2020
pubmed: 29 10 2020
medline: 5 11 2020
Statut: ppublish

Résumé

Tongue cancer is more common in men than in women. Yet the effects of sex steroid hormones on the behaviour of oral tongue squamous cell carcinoma (OTSCC) are not well known. Matrix metalloproteinase 8 (MMP8) is expressed in OTSCC and can degrade estrogen receptors (ERs). Western blot was used to examine the levels of ERβ in OTSCC cell lines (HSC-3 and SCC-25). We evaluated the effects of estradiol and dihydrotestosterone (DHT) on HSC-3 and SCC-25 cell migration, invasion and viability. The effect of estradiol on the invasion of MMP8-overexpressing (MMP8 Both HSC-3 and SCC-25 cells expressed ERβ. In scratch assay, estradiol, but not DHT, reduced the migration and invasion of HSC-3 and SCC-25 cells. MMP8 Estradiol inhibited the migration and invasion of OTSCC cells, whereas DHT had no effect. Our data suggest that MMP8 does not modulate the effect of estradiol in OTSCC cells. However, the sex difference in OTSCC incidence might partly be due to protective actions of estradiol in epithelial cell carcinogenesis.

Sections du résumé

BACKGROUND BACKGROUND
Tongue cancer is more common in men than in women. Yet the effects of sex steroid hormones on the behaviour of oral tongue squamous cell carcinoma (OTSCC) are not well known. Matrix metalloproteinase 8 (MMP8) is expressed in OTSCC and can degrade estrogen receptors (ERs).
MATERIALS AND METHODS METHODS
Western blot was used to examine the levels of ERβ in OTSCC cell lines (HSC-3 and SCC-25). We evaluated the effects of estradiol and dihydrotestosterone (DHT) on HSC-3 and SCC-25 cell migration, invasion and viability. The effect of estradiol on the invasion of MMP8-overexpressing (MMP8
RESULTS RESULTS
Both HSC-3 and SCC-25 cells expressed ERβ. In scratch assay, estradiol, but not DHT, reduced the migration and invasion of HSC-3 and SCC-25 cells. MMP8
CONCLUSION CONCLUSIONS
Estradiol inhibited the migration and invasion of OTSCC cells, whereas DHT had no effect. Our data suggest that MMP8 does not modulate the effect of estradiol in OTSCC cells. However, the sex difference in OTSCC incidence might partly be due to protective actions of estradiol in epithelial cell carcinogenesis.

Identifiants

pubmed: 33109541
pii: 40/11/6029
doi: 10.21873/anticanres.14624
doi:

Substances chimiques

Estrogen Receptor beta 0
Gonadal Steroid Hormones 0
Dihydrotestosterone 08J2K08A3Y
Estradiol 4TI98Z838E
Matrix Metalloproteinase 8 EC 3.4.24.34

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6029-6037

Informations de copyright

Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Auteurs

Johanna Peltonen (J)

Department of Oral and Maxillofacial Diseases, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland johanna.peltonen@helsinki.fi.
Translational Immunology Research Program (TRIMM), University of Helsinki, Helsinki, Finland.

Katja Tuomainen (K)

Department of Oral and Maxillofacial Diseases, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Translational Immunology Research Program (TRIMM), University of Helsinki, Helsinki, Finland.

Tobias Sallinen (T)

Department of Oral and Maxillofacial Diseases, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Islam Faress (I)

Department of Oral and Maxillofacial Diseases, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Department of Molecular Biology and Genetics, University of Århus, Århus, Denmark.

Ilida Suleymanova (I)

Department of Oral and Maxillofacial Diseases, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Translational Immunology Research Program (TRIMM), University of Helsinki, Helsinki, Finland.

Ahmed Al-Samadi (A)

Department of Oral and Maxillofacial Diseases, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Translational Immunology Research Program (TRIMM), University of Helsinki, Helsinki, Finland.

Tuula Salo (T)

Department of Oral and Maxillofacial Diseases, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Translational Immunology Research Program (TRIMM), University of Helsinki, Helsinki, Finland.
Cancer and Translational Medicine Research Unit, Faculty of Medicine, University of Oulu, Oulu, Finland.
Department of Pathology, University of Helsinki, Helsinki, Finland.

Pirjo ÅstrÖm (P)

Research Unit of Biomedicine, University of Oulu, Oulu, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH